Emcure Pharmaceuticals Ltd. - Research Center
544210 EMCURE Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Profit before tax | 212.34 | 616.42 | 557.45 | 224.68 | 369.84 |
| Net cashflow-operating activity | 505.37 | 427.71 | 774.87 | 385.25 | 371.17 |
| Net cash used in investing activity | -270.44 | -189.00 | -831.16 | -164.76 | -275.76 |
| Netcash used in fin. activity | -54.52 | -342.96 | 30.97 | -45.87 | -53.46 |
| Net inc/dec in cash and equivlnt | 180.30 | -309.06 | -29.94 | 170.45 | 41.81 |
| Cash and equivalnt begin of year | -393.35 | -84.29 | -54.35 | -224.80 | -266.60 |
| Cash and equivalnt end of year | -213.05 | -393.35 | -84.29 | -54.35 | -224.80 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis